A phase I trial of carboplatin and etoposide for elderly (≥75 year-old) patients with small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 601, doi. 10.1007/s00280-006-0188-7
- By:
- Publication type:
- Article
Works in Cancer Chemotherapy & Pharmacology, 2006, Vol 58, Issue 5
Results: 21
1
2
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 711, doi. 10.1007/s00280-005-0182-5
- By:
- Publication type:
- Article
4
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 692, doi. 10.1007/s00280-006-0213-x
- By:
- Publication type:
- Article
5
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 716, doi. 10.1007/s00280-005-0181-6
- By:
- Publication type:
- Article
6
Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 607, doi. 10.1007/s00280-006-0208-7
- By:
- Publication type:
- Article
7
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 654, doi. 10.1007/s00280-006-0203-z
- By:
- Publication type:
- Article
8
A phase II trial of O <sup>6</sup>-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 634, doi. 10.1007/s00280-006-0210-0
- By:
- Publication type:
- Article
9
Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 577, doi. 10.1007/s00280-006-0219-4
- By:
- Publication type:
- Article
10
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 570, doi. 10.1007/s00280-006-0193-x
- By:
- Publication type:
- Article
11
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 673, doi. 10.1007/s00280-006-0221-x
- By:
- Publication type:
- Article
12
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.
- Published in:
- 2006
- By:
- Publication type:
- journal article
13
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 703, doi. 10.1007/s00280-006-0201-1
- By:
- Publication type:
- Article
14
The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 699, doi. 10.1007/s00280-006-0206-9
- By:
- Publication type:
- Article
15
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 626, doi. 10.1007/s00280-006-0202-0
- By:
- Publication type:
- Article
16
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
- Published in:
- 2006
- By:
- Publication type:
- journal article
17
Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 665, doi. 10.1007/s00280-006-0209-6
- By:
- Publication type:
- Article
18
High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 561, doi. 10.1007/s00280-006-0211-z
- By:
- Publication type:
- Article
19
Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M<sub>4</sub>N and maltose-M<sub>3</sub>N, and their use in combination with doxorubicin or paclitaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 640, doi. 10.1007/s00280-006-0214-9
- By:
- Publication type:
- Article
20
Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib.
- Published in:
- 2006
- By:
- Publication type:
- journal article
21
Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 618, doi. 10.1007/s00280-006-0225-6
- By:
- Publication type:
- Article